VAQTA (hepatitis A virus vaccine/PF)
HEPATITIS A VIRUS VACCINE · HEPATITIS A VACCINATION
Merck Sharp & Dohme
Drug class
Hepatitis A Virus Vaccine
Hepatitis A virus vaccines belong to an immunobiologic drug class composed of inactivated, whole-virus antigens, available either as monovalent formulations or combined with other viral antigens. Read more about Hepatitis A Virus Vaccine
11 drugs in this class 3 manufacturers
Drugs in Hepatitis A Virus Vaccine
HAVRIX (hepatitis A virus vaccine/PF)
HEPATITIS A VIRUS VACCINE · HEPATITIS A VACCINATION
GSK
TWINRIX (hepatitis A virus and hepatitis B virus vaccine/PF)
HEPATITIS B VACCINE · HEPATITIS B VACCINATION ·+1
GSK
VAQTA (hepatitis A virus vaccine/PF)
HEPATITIS A VIRUS VACCINE · HEPATITIS A VACCINATION
Merck Sharp & Dohme
VAQTA (hepatitis A virus vaccine/PF)
HEPATITIS A VIRUS VACCINE · HEPATITIS A VACCINATION
Merck Sharp & Dohme
HAVRIX (hepatitis A virus vaccine/PF)
HEPATITIS A VIRUS VACCINE · HEPATITIS A VACCINATION
GSK
HAVRIX (PF) (hepatitis A virus vaccine/PF)
HEPATITIS A VIRUS VACCINE · HEPATITIS A VACCINATION
GSK
VAQTA (PF) (hepatitis A virus vaccine/PF)
HEPATITIS A VIRUS VACCINE · HEPATITIS A VACCINATION
Merck Sharp & Dohme
VAQTA (PF) (hepatitis A virus vaccine/PF)
HEPATITIS A VIRUS VACCINE · HEPATITIS A VACCINATION
Merck Sharp & Dohme
Filter & compare in the drug finder →
Opens the drug finder with Hepatitis A Virus Vaccine preselected. Add indication or manufacturer filters there.
Hepatitis A virus vaccines belong to an immunobiologic drug class composed of inactivated, whole-virus antigens, available either as monovalent formulations or combined with other viral antigens.
They function by inducing active immunity through the production of specific neutralizing antibodies against the hepatitis A virus, conferring long-term protection against infection.
Clinically, these vaccines are indicated for pre-exposure prophylaxis in routine pediatric immunization schedules, high-risk adult populations, and international travelers, as well as for post-exposure prophylaxis following acute virus exposure.
-
fda.gov
Hepatitis A virus vaccines belong to an immunobiologic drug class composed of inactivated, whole-virus antigens, available either as monovalent formulations or combined with other viral antigens
-
cdc.gov
Hepatitis A virus vaccines belong to an immunobiologic drug class composed of inactivated, whole-virus antigens, available either as monovalent formulations or combined with other viral antigens
-
fda.gov
They function by inducing active immunity through the production of specific neutralizing antibodies against the hepatitis A virus, conferring long-term protection against infection Clinically, these vaccines are indicated for pre-exposure prophylaxis in routine pediatric immunization schedules, high-risk adult populations, and international travelers, as well as for post-exposure prophylaxis following acute virus exposure
-
fda.gov
They function by inducing active immunity through the production of specific neutralizing antibodies against the hepatitis A virus, conferring long-term protection against infection
-
cdc.gov
They function by inducing active immunity through the production of specific neutralizing antibodies against the hepatitis A virus, conferring long-term protection against infection
-
fda.gov
Clinically, these vaccines are indicated for pre-exposure prophylaxis in routine pediatric immunization schedules, high-risk adult populations, and international travelers, as well as for post-exposure prophylaxis following acute virus exposure
-
cdc.gov
Clinically, these vaccines are indicated for pre-exposure prophylaxis in routine pediatric immunization schedules, high-risk adult populations, and international travelers, as well as for post-exposure prophylaxis following acute virus exposure
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.